SEC Form 4 research
| Issuer | BridgeBio Oncology Therapeutics, Inc. |
|---|---|
| Tickers | BBOT, HLXB |
| Reporting owners | 22 |
| Officers and directors | 1 |
| Last public filing | 2026-09-14 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-14 | 2026-09-10 | Cobo Marc | A | 9,038 | $0 | Not reported |
| 2026-09-14 | 2026-09-10 | Cobo Marc | A | 43,700 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.